News
The FDA approved Welireg for adult and pediatric patients 12 and older with locally advanced, unresectable or metastatic ...
MedPage Today on MSN2d
Zepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...
Immune checkpoint inhibitors have shown a survival benefit in patients with metastatic urothelial cancer, so investigators trialed neoadjuvant nivolumab and ipilimumab in patients with muscle-invasive ...
Asian News International on MSN2d
Weight loss drug Mounjaro shown more effective than Wegovy, claims Pharma companyEli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial, evaluating ...
Reported positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 demonstrating dose-dependent decreases in blood LDL-C and PCSK9< ...
The Print on MSN1d
Mounjaro vs Wegovy: Guess which obesity drug outperformed the other by a mile in head-to-head trialBoth medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...
Our Bureau, Mumbai Monday, May 12, 2025, 14:45 Hrs [IST] ...
Patients with HIV can take both their antiretroviral therapy (ART) and treatment to prevent tuberculosis safely to prevent ...
News-Medical.Net on MSN1d
Tirzepatide outperforms semaglutide for weight loss in people without diabetesA head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...
MedPage Today on MSN2d
One Immunosuppressant Superior for Preventing Nephrotic Syndrome Relapse in KidsTacrolimus outshined another immunosuppressive drug at extending relapse-free survival in kids with frequently relapsing or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback